Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
By
Digital transformation is an ongoing process. Here’s how your company can hone its funding, expertise, and technological capabilities.
By
Digital transformations aren’t just about technology. Employees need to have the right skills, support, and emotional space to adjust during the transitions.
Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.
By
Investing in the right projects requires showing evidence of value, holding individuals accountable, and creating a transparent process.
By
Decontextualize data and prepare data assets that can be reused for many purposes. A new book from MIT CISR researchers explains how.
By
Becoming digital isn’t the same as digitization. Here’s how to handle both digital transformations.
By
Top tech leaders are spending less time collaborating with peers and more time meeting customers and developing innovations.
By
Five steps toward a critical mass of directors who understand.
